Glycoprotein IIb/IIIa inhibitors use and outcome after percutaneous coronary intervention for non-ST elevation myocardial infarction.

Biomed Res Int · 2014 · PMC4034401 · PMID 24895595

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

a nonsignificant trendP = 0.110not close (p > 0.1)

However, eptifibatide (67 patients) showed a nonsignificant trend for decreased mortality ( P = 0.110).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.